Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose N-acetylcysteine for obstructive sleep apnea syndrome
ChiCTR-TRC-14004578Phase 4Completed
- Sponsor
- Tianjin Medical University General Hospital
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in obstructive sleep apnea hypopnea syndrome (OSAHS) comparing N-acetylcysteine with Placebo (2 arms). Primary endpoints: apnea-hypopnea index, lowest oxygen saturation and 1 more. Started May 2014; status: completed.
02
Drugs
acetylcysteine
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ChiCTR-TRC-14004578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004578.